✦ LIBER ✦

Acute and Long-Term Toxicities Associated with Gemtuzumab Ozogamicin (Mylotarg®) Therapy of Acute Myeloid Leukemia

✍ Scribed by Leopold, Lance H.; Berger, Mark S.; Feingoldr, Jay

Book ID: 119935739
Publisher: CIG Media Group, LP.
Year: 2002
Tongue: English
Weight: 112 KB
Volume: 2
Category: Article
ISSN: 1526-9655
DOI: 10.3816/clm.2002.s.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and toxicity of gemtuzumab ozog

Efficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemia

✍ P. L. J. van der Heiden; I. Jedema; R. Willemze; R. M. Y. Barge 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Antibody-targeted chemotherapy of older

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)

✍ Larson, R A; Boogaerts, M; Estey, E; Karanes, C; Stadtmauer, E A; Sievers, E L; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 163 KB

Cytotoxic activity of gemtuzumab ozogami

Cytotoxic activity of gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia correlates with the expression of protein kinase Syk

✍ Balaian, L; Ball, E D 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 171 KB

Decitabine combined with fractionated ge

Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia

✍ Saeeda Chowdhury; Stuart Seropian; Peter W. Marks 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Final report of the efficacy and safety

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

✍ Richard A. Larson; Eric L. Sievers; Edward A. Stadtmauer; Bob Löwenberg; Elihu H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views

Gemtuzumab ozogamicin, mitoxantrone, and

Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy

✍ Michael Boyiadzis; Robert L. Redner; Anastasios Raptis; Jing-Zhou Hou; Mounzer A 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 71 KB